REVELATION BIOSCIENCES, INC. (REVB) Operating cash flow 2020–2025
REVELATION BIOSCIENCES, INC. (REVB) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$8.3MFY2025 · since FY2020: -$216,664 → -$8.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$8.3M | +54.9% |
| FY2024 | -$18.3M | -151.4% |
| FY2023 | -$7.3M | +35.1% |
| FY2022 | -$11.2M | -1.2% |
| FY2021 | -$11.1M | -5018.8% |
| FY2020 | -$216,664 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More REVB financial trends
REVB RevenueREVB Net incomeREVB Net marginREVB Gross profitREVB Gross marginREVB Operating incomeREVB Operating marginREVB Free cash flowREVB Capital expendituresREVB Return on equityREVB Stock buybacksREVB Dividends paidREVB Total assetsREVB Total liabilitiesREVB Shareholders’ equityREVB overview →